Revascularization Trends in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease Presenting With Non–ST Elevation Myocardial Infarction
Authors:
- Ambarish PandeyAPAmbarish Pandey
- Darren K. McGuireDMDarren K. McGuire
- James A. de LemosJLJames A. de Lemos
- Sandeep R. DasSDSandeep R. Das
- Jarett D. BerryJBJarett D. Berry
- Emmanouil S. BrilakisEBEmmanouil S. Brilakis
- Subhash BanerjeeSBSubhash Banerjee
- Steven P. MarsoSMSteven P. Marso
- Gregory W. BarsnessGBGregory W. Barsness
- DaJuanicia N. SimonDSDaJuanicia N. Simon
- Matthew RoeMRMatthew Roe
- Abhinav GoyalAGAbhinav Goyal
- 1 May 2016
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Quality and Outcomes
- Vol. 9 (3) , 197-205
Abstract
Background—: Current guidelines recommend surgical revascularization (coronary artery bypass graft [CABG]) over percutaneous coronary intervention (PCI) in patients with diabetes mellitus and multivessel coronary artery disease. Few data are available describing revascularization patterns among these patients in the setting of non–ST-segment–elevation myocardial infarction. Methods and Results—: Using Acute Coronary Treatment and Intervention Outcomes Network Registry–Get with the Guidelines (ACTION Registry–GWTG), we compared the in-hospital use of different revascularization strategies (PCI versus CABG versus no revascularization) in diabetes mellitus patients with non–ST-segment–elevation myocardial infarction who had angiography, demonstrating multivessel coronary artery disease between July 2008 and December 2014. Factors associated with use of CABG versus PCI were identified using logistic multivariable regression analyses. A total of 29 769 patients from 539 hospitals were included in the study, of which 10 852 (36.4%) were treated with CABG, 13 760 (46.2%) were treated with PCI, and 5157 (17.3%) were treated without revascularization. The overall use of revascularization increased over the study period with an increase in the proportion undergoing PCI (45% to 48.9%; P trend =0.0002) and no change in the proportion undergoing CABG (36.1% to 34.7%; p trend =0.88). There was significant variability between participating hospitals in the use of PCI and CABG (range: 22%–100%; 0%–78%, respectively; P value <0.0001 for both). Patient-level, but not hospital-level, characteristics were statistically associated with the use of PCI versus CABG, including anatomic severity of the disease, early treatment of adenosine diphosphate receptor antagonists at presentation, older age, female sex, and history of heart failure. Conclusions—: Among patients with diabetes mellitus and multivessel coronary artery disease presenting with non–ST-segment–elevation myocardial infarction, only one third undergo CABG during the index admission. Furthermore, the use of PCI, but not CABG, increased modestly over the past 6 years.Keywords
This publication has 29 references indexed in Scilit:
- The Relationship Between Metabolic Risk Factors and Incident Cardiovascular Disease in Europeans, South Asians, and African CaribbeansJACC, 2013
- Strategies for Multivessel Revascularization in Patients with DiabetesNew England Journal of Medicine, 2012
- Temporal trends and practice variations in clopidogrel loading doses in patients with non–ST-segment elevation myocardial infarction, from the National Cardiovascular Data RegistryAmerican Heart Journal, 2011
- The global burden of diabetes and its complications: an emerging pandemicEuropean Journal of Preventive Cardiology, 2010
- A Call to ACTION (Acute Coronary Treatment and Intervention Outcomes Network)Circulation: Cardiovascular Quality and Outcomes, 2009
- Drug-Eluting Stents and the Use of Percutaneous Coronary Intervention Among Patients With Class I Indications for Coronary Artery Bypass Surgery Undergoing Index RevascularizationJACC: Cardiovascular Interventions, 2009
- Changes in Patterns of Coronary Revascularization Strategies for Patients With Acute Coronary Syndromes (from the CRUSADE Quality Improvement Initiative)The American Journal of Cardiology, 2007
- Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control studyThe Lancet, 2004
- Influence of the Bypass Angioplasty Revascularization Investigation National Heart, Lung, and Blood Institute Diabetic Clinical Alert on Practice PatternsCirculation, 2003
- Comparison of Coronary-Artery Bypass Surgery and Stenting for the Treatment of Multivessel DiseaseNew England Journal of Medicine, 2001